Blood, as a specialized connective tissue, embodies a complex interplay between its fluid matrix and cellular components. Plasma provides the biochemical environment that sustains and regulates physiological processes, while red blood cells ensure efficient gas transport, white blood cells orchestrate immune defense, and platelets safeguard vascular integrity through hemostasis. Together, these constituents maintain homeostasis and enable the survival of multicellular organisms. Disruptions in any of these components, whether in concentration, structure, or function, are central to numerous pathologies including anemia, coagulopathies, leukemias, and thrombotic disorders. The clinical importance of blood is thus reflected not only in diagnostics but also in therapeutic strategies, ranging from transfusion medicine and immunotherapy to anticoagulant and antiplatelet therapies. High-resolution multi-omics approaches are uncovering novel biomarkers and therapeutic targets for systemic diseases such as cancer, cardiovascular disorders, and autoimmune conditions. Furthermore, precision medicine and stem cell-based therapies hold promise for tailoring treatments to individual patients, potentially transforming hematology from a primarily supportive discipline to one at the forefront of personalized healthcare.